Drug Information
| Drug General Information | Top | |||
|---|---|---|---|---|
| Drug ID |
D0K3FX
|
|||
| Former ID |
DIB011354
|
|||
| Drug Name |
NT-503
|
|||
| Synonyms |
VEGF antagonist cell-based implant (ECT, wet AMD), Neurotech
Click to Show/Hide
|
|||
| Indication | Age-related macular degeneration [ICD-11: 9B75.0; ICD-9: 362.5] | Phase 1/2 | [1] | |
| Company |
Neurotech Pharmaceuticals Inc
|
|||
| References | Top | |||
|---|---|---|---|---|
| REF 1 | ClinicalTrials.gov (NCT02228304) Study of the Intravitreal Implantation of NT-503-3 Encapsulated Cell Technology (ECT) for the Treatment of Recurrent Choroidal Neovascularization (CNV) Secondary to Age-related Macular Degeneration (AMD). U.S. National Institutes of Health. | |||
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.